medisourceasia.com

Industry News


About 
medisourceasia

Magazine
Industry News
Global Trends
Events Calendar
Web Links

Web Gallery

Advertising  Info

Contact

 

Medtronic new product for diabetics

US-based medical technologies company Medtronic has launched a product, which combines insulin pump with continuous glucose readings and trend graphs. MiniMed Paradigm Real-time Insulin Pump and Continuous Glucose Monitoring system allows a patient to make immediate self-management decisions to improve their glucose control after confirming readings with a fingerstick measurement, Medtronic business manager Adrian Gut said.

The MiniMed Paradigm Real Time system integrates an external insulin pump with continuous glucose monitoring (CGM). The system’s glucose sensor takes as many as 288 daily glucose readings per day, providing nearly 100 times more information than three daily finger stick readings provided.

"By viewing trends and real-time glucose information, patients can programme their pump to start or stop insulin delivery upon demand or can eat carbohydrates to counteract low blood sugar. Timely information coupled with precise insulin delivery is why this integrated insulin therapy has the potential to revolutionise diabetes management," Mohan’s diabetes specialities centre chairman V Mohan said.

(Ref : Economic Times dated October 13, 2006)

Baxter Inc Aligns Indian Operations

Baxter International Inc, a $9.8 billion integrated healthcare solutions provider of critical therapies, is aligning operations of its Indian subsidiary with itself. For starters, Baxter will shorten the launch cycle of its blockbuster global products in India. The company also plans to initiate global clinical trials and design home dialysis instruments in India.

Baxter's present launch cycle of new products in India is a high as five years from their original global launch date. "This period will significantly shrink and our global products will be launched in India much faster. This is largely due to maturity of the home dialysis market in India," said Mr Sanjiv Navangul, business unit director (renal) at Baxter India.

The company may also conduct global trials for future products in India. "We work with Indian scientists and physicians to develop future products at our US R&D facility. There's the possibility of working with medicos here for clinical trials," said Mr. Navangul.

(Ref : Economic Times dated October 13, 2006)


Next

Other News

Space Hospitals To Widen Telemedicine Services Throughout India
Dr. M. Venkateswarulu Takes Charge As Drugs Controller of India (DCGI)
Imported Non-Sterile Medical Devices Meant For Sterile Use Need Mandatory Registration
HLL to venture into vaccine manufacturing, sets sales target of Rs.1000 cr by 2010
India, China To Account For 25 Percent Global Analytical Equipment Market By 2007
Plastindia Foundation: New Team of Office Bearers for the term 2006 – 2009

Archives

Advertisement

 

 


Back | Back To Top | Previous | Next